PREGABALIN LAPL pregabalin 300 mg capsule blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

pregabalin, Quantity: 300 mg

Pieejams no:

Lupin Australia Pty Limited

SNN (starptautisko nepatentēto nosaukumu):

Pregabalin

Zāļu forma:

Capsule, hard

Kompozīcija:

Excipient Ingredients: pregelatinised maize starch; purified talc; titanium dioxide; purified water; iron oxide red; Gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute

Ievadīšanas:

Oral

Vienības iepakojumā:

20, 60, 14, 56

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Pregabalin LAPL is indicated for the treatment of neuropathic pain in adults. Pregabalin LAPL is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Produktu pārskats:

Visual Identification: Size '0' capsules with dark brown cap and white body, imprinted with "PG" on cap and "300" on body in black ink, containing white to off white powder.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizācija statuss:

Licence status A

Autorizācija datums:

2014-12-05